TY  - GEN
AU  - Johnson,David H
AU  - Fehrenbacher,Louis
AU  - Novotny,William F
AU  - Herbst,Roy S
AU  - Nemunaitis,John J
AU  - Jablons,David M
AU  - Langer,Corey J
AU  - DeVore,Russell F
AU  - Gaudreault,Jacques
AU  - Damico,Lisa A
AU  - Holmgren,Eric
AU  - Kabbinavar,Fairooz
TI  - Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer
SN  - 0732-183X
PY  - 2004///0618
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bevacizumab
KW  - Carboplatin
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Paclitaxel
KW  - Proportional Hazards Models
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1200/JCO.2004.11.022
ER  -